Derivative Liabilities - Fair Value
Amgen Derivative Liabilities - Fair Value decreased by 4.2% to $792.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 10.0%, from $880.00M to $792.00M. Over 3 years (FY 2022 to FY 2025), Derivative Liabilities - Fair Value shows a downward trend with a -16.1% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
An increase in liabilities suggests unfavorable market movements for the company's hedges, while a decrease indicates a reduction in potential settlement obligations.
Detailed definition
This represents the fair value of derivative financial instruments that are currently in a liability position. These lia...
Peer comparison
Standard for energy companies; peers with similar hedging profiles will show comparable volatility in this line item.
derivative_liabilities_fair_valueHistorical Data
| Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.40B | $1.25B | $1.31B | $1.31B | $1.09B | $1.07B | $1.03B | $886.00M | $1.02B | $880.00M | $1.02B | $904.00M | $827.00M | $792.00M |
| QoQ Change | — | -10.4% | +4.7% | +0.2% | -16.9% | -1.8% | -4.2% | -13.7% | +15.3% | -13.9% | +15.8% | -11.3% | -8.5% | -4.2% |
| YoY Change | — | — | — | — | -21.9% | -14.4% | -21.7% | -32.6% | -6.4% | -17.9% | -0.8% | +2.0% | -19.1% | -10.0% |
Derivative Liabilities - Fair Value at Other Companies
Frequently Asked Questions
- What is Amgen's derivative liabilities - fair value?
- Amgen (AMGN) reported derivative liabilities - fair value of $792.00M in Q1 2026.
- How has Amgen's derivative liabilities - fair value changed year-over-year?
- Amgen's derivative liabilities - fair value decreased by 10.0% year-over-year, from $880.00M to $792.00M.
- What is the long-term trend for Amgen's derivative liabilities - fair value?
- Over 3 years (2022 to 2025), Amgen's derivative liabilities - fair value has grown at a -16.1% compound annual growth rate (CAGR), from $1.40B to $827.00M.
- What does derivative liabilities - fair value mean?
- The total market value of all derivative contracts that are currently resulting in a loss.